For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

A BU professor warns that federal funding cuts, immigration restrictions and housing costs could reshape the region's status ...

Robert F. Kennedy Jr. dismissed all members of the CDC’s Advisory Committee on Immunization Practices, which recommends which ...

Most internal ventures fail not from bad ideas, but bad design. Learn how future-focused leaders are building smarter systems ...